United States · Funded startup
4 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$86Mraised across 4 rounds since 2003, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $39M sold, first sale Oct 2009
New Enterprise Associates
Novartis Venture Fund
Alliance Technology Ventures
Sanofi-Genzyme BioVenturesReported by onbiovc.comSEC filing: $39M sold, first sale Oct 2009
New Enterprise AssociatesNovartis Venture FundAlliance Technology Ventures
PTV Healthcare CapitalFrom a historical funding record
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
GlycoMimetics's investors include New Enterprise Associates, Novartis Venture Fund, Alliance Technology Ventures, Anthem Capital Management and Maryland Department of Business and Economic Development, and 2 more on record.
GlycoMimetics has raised $86M across 4 rounds since 2003.
GlycoMimetics's most recent round was an Undisclosed round of $39M in Oct 2010.
Its most recent round, $39M in Oct 2010, is also its largest on record.
GlycoMimetics's first round on record, in May 2003, was backed by New Enterprise Associates, Novartis Venture Fund and Alliance Technology Ventures and 1 others.
GlycoMimetics's latest named round is an Undisclosed round, in Oct 2010.
GlycoMimetics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·